Weber-Cockayne Syndrome
2 clinical trials · Condition
◉ Watch Weber-Cockayne Syndrome
| Record | Firm | Date |
|---|---|---|
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study (NCT03016715) | Premier Specialists, Australia | 2016-05-01 |
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study (NCT02960997) | Stanford University | 2016-05-01 |
Track Weber-Cockayne Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.